Detalles de la búsqueda
1.
Literature review of visual representation of the results of benefit-risk assessments of medicinal products.
Pharmacoepidemiol Drug Saf
; 25(3): 238-50, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26521865
2.
Recommendations for benefit-risk assessment methodologies and visual representations.
Pharmacoepidemiol Drug Saf
; 25(3): 251-62, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26800458
3.
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Pharmacoepidemiol Drug Saf
; 23(7): 667-78, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24821575
4.
Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.
Pharmacoepidemiol Drug Saf
; 23(9): 974-83, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25043919
5.
Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study.
Ther Innov Regul Sci
; 50(5): 620-631, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30231761
6.
Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance.
Drug Saf
; 26(11): 815-27, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12908850
Resultados
1 -
6
de 6
1
Próxima >
>>